SCHEMBL19002175

SCHEMBL19002175

CCC(CC(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC15A1 P46059 2/20 0.57
ALDH1A1 P00352 4/20 0.54
MAPK1 P28482 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
CDC25B P30305 1/20 0.46
CA1 P00915 1/20 0.44
MMP9 P14780 1/20 0.44
ABCB1 P08183 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
CYP3A4 P08684 2/20 0.43
TSHR P16473 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2858801 0.94 SLC15A1 (0.51) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL16342313 0.90 SLC15A1 (0.57) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL8436634 0.88 ALDH1A1 (0.60) ALDH1A1MAPK1L3MBTL1KMT2ATDP1
SCHEMBL18300761 0.88 SLC15A1 (0.54) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL20805205 0.85 SLC15A1 (0.55) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL27556474 0.84 SLC15A1 (0.58) SLC15A1ALDH1A1MAPK1L3MBTL1MMP9
SCHEMBL27556472 0.84 SLC15A1 (0.58) SLC15A1ALDH1A1MAPK1L3MBTL1MMP9
SCHEMBL17617234 0.83 CYP1A2 (0.58) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL23811129 0.82 ALDH1A1 (0.53) SLC15A1ALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL6050184 0.82 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181547-B1 METHOD FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS EVONIK DEGUSSA GMBH (DE) 2018-04-04 EP disclosed
US-9815766-B2 Process for double carbonylation of allyl ethers to corresponding diesters EVONIK DEGUSSA GMBH (DE) 2017-11-14 US disclosed
US-20170174609-A1 PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS EVONIK DEGUSSA GMBH (DE) 2017-06-22 US disclosed
EP-3181547-A1 METHOD FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS Evonik Degussa GmbH (DE) 2017-06-21 EP disclosed
CN-102781970-A Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA SRL 2012-11-14 CN disclosed
CN-102597022-A Process for preparing impact resistant propylene polymer compositions BASELL POLIOLEFINE SRL 2012-07-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174609-A1 PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS CBR3, CBR1, EPOR SLC15A1 4838/4885ALDH1A1 311/4885MAPK1 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.